Safety of iron milk proteinate as a novel ...
Document type :
Article dans une revue scientifique: Article original
DOI :
PMID :
Permalink :
Title :
Safety of iron milk proteinate as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of iron from this source in the context of Directive 2002/46/EC
Author(s) :
Turck, Dominique [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Castenmiller, J. [Auteur]
European Food Safety Authority [EFSA]
De Henauw, S. [Auteur]
Hirsch-Ernst, K. I. [Auteur]
Maciuk, A. [Auteur]
Mangelsdorf, I. [Auteur]
Mcardle, H. J. [Auteur]
Naska, A. [Auteur]
Pelaez, C. [Auteur]
Pentieva, K. [Auteur]
Siani, A. [Auteur]
Thies, F. [Auteur]
Tsabouri, S. [Auteur]
Vinceti, M. [Auteur]
Cubadda, F. [Auteur]
Frenzel, T. [Auteur]
Heinonen, M. [Auteur]
Maradona, M. P. [Auteur]
Marchelli, R. [Auteur]
Neuhauser-Berthold, M. [Auteur]
Poulsen, M. [Auteur]
Schlatter, J. R. [Auteur]
Van Loveren, H. [Auteur]
Acker, R. [Auteur]
Knutsen, H. K. [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Castenmiller, J. [Auteur]
European Food Safety Authority [EFSA]
De Henauw, S. [Auteur]
Hirsch-Ernst, K. I. [Auteur]
Maciuk, A. [Auteur]
Mangelsdorf, I. [Auteur]
Mcardle, H. J. [Auteur]
Naska, A. [Auteur]
Pelaez, C. [Auteur]
Pentieva, K. [Auteur]
Siani, A. [Auteur]
Thies, F. [Auteur]
Tsabouri, S. [Auteur]
Vinceti, M. [Auteur]
Cubadda, F. [Auteur]
Frenzel, T. [Auteur]
Heinonen, M. [Auteur]
Maradona, M. P. [Auteur]
Marchelli, R. [Auteur]
Neuhauser-Berthold, M. [Auteur]
Poulsen, M. [Auteur]
Schlatter, J. R. [Auteur]
Van Loveren, H. [Auteur]
Acker, R. [Auteur]
Knutsen, H. K. [Auteur]
Journal title :
EFSA Journal
Abbreviated title :
EFSA J.
Volume number :
20
Pages :
-
Publication date :
2022-09-25
ISSN :
1831-4732
English keyword(s) :
iron milk proteinate
novel food
nutrient source
iron
bioavailability
safety
novel food
nutrient source
iron
bioavailability
safety
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods andFood Allergens (NDA) was asked to deliver an opinion on iron milk proteinate as a novel food (NF)pursuant to Regulation (EU) ...
Show more >Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods andFood Allergens (NDA) was asked to deliver an opinion on iron milk proteinate as a novel food (NF)pursuant to Regulation (EU) 2015/2283 and to address the bioavailability of iron from this source inthe context of Directive 2002/46/EC. The NF is a complex of iron, casein and phosphate, which isproduced from iron salts (i.e. ferric chloride or ferric sulfate), sodium caseinate and potassiumorthophosphate. The NF is proposed by the applicant to be used as a source of iron, of which the NFcontains 2–4%. The applicant intends to market the NF as an ingredient in a number of foodcategories; in food supplements, in total diet replacement for weight control and in foods for specialmedical purposes. The Panel considers that, taking into account the composition of the NF and theproposed conditions of use, consumption of the NF is not nutritionally disadvantageous. The studiesprovided for ADME and bioavailability indicate that iron from the NF is bioavailable. Overall, theevidence indicates that upon ingestion the NF undergoes digestion into small peptides to yield iron-bound caseinophosphopeptides that are normal constituents of the human diet, and that the iron fromthe NF does not bypass the homeostatic control of iron as a nutrient. The Panel concludes that the NF,iron milk proteinate, is safe under the proposed conditions of use. The Panel also concludes that theNF is a source from which iron is bioavailable.Show less >
Show more >Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods andFood Allergens (NDA) was asked to deliver an opinion on iron milk proteinate as a novel food (NF)pursuant to Regulation (EU) 2015/2283 and to address the bioavailability of iron from this source inthe context of Directive 2002/46/EC. The NF is a complex of iron, casein and phosphate, which isproduced from iron salts (i.e. ferric chloride or ferric sulfate), sodium caseinate and potassiumorthophosphate. The NF is proposed by the applicant to be used as a source of iron, of which the NFcontains 2–4%. The applicant intends to market the NF as an ingredient in a number of foodcategories; in food supplements, in total diet replacement for weight control and in foods for specialmedical purposes. The Panel considers that, taking into account the composition of the NF and theproposed conditions of use, consumption of the NF is not nutritionally disadvantageous. The studiesprovided for ADME and bioavailability indicate that iron from the NF is bioavailable. Overall, theevidence indicates that upon ingestion the NF undergoes digestion into small peptides to yield iron-bound caseinophosphopeptides that are normal constituents of the human diet, and that the iron fromthe NF does not bypass the homeostatic control of iron as a nutrient. The Panel concludes that the NF,iron milk proteinate, is safe under the proposed conditions of use. The Panel also concludes that theNF is a source from which iron is bioavailable.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Submission date :
2024-01-12T00:30:02Z
2024-03-08T14:55:45Z
2024-03-08T14:55:45Z
Files
- EFSA Journal - 2022 - - Safety of iron milk proteinate as a novel food pursuant to Regulation EU 2015 2283 and.pdf
- Version éditeur
- Open access
- Access the document
Except where otherwise noted, this item's license is described as Attribution-NoDerivs 3.0 United States